Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones.
about
Chromogranin A is an autoantigen in type 1 diabetesThe diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinityReactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation.Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chainsUse of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetesSusceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.Modulation of redox balance leaves murine diabetogenic TH1 T cells "LAG-3-ing" behind.Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetesDiabetogenic T-cell clones recognize an altered peptide of chromogranin A.Vaccination with single chain antigen receptors for islet-derived peptides presented on I-A(g7) delays diabetes in NOD mice by inducing anergy in self-reactiveT-cells.Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice.Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice.Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells
P2860
Q24605199-D00ACB54-0EE8-447C-BA16-602991AE5132Q27660688-3FEA2B9D-BB33-42CE-8C81-96FDEF8C1134Q33584702-75A23897-1784-4CA8-B97E-78E46331A88EQ35248766-FBDC1601-2AE0-4816-970F-BD1D20F83E10Q35651667-23415464-CC6F-4B8F-B512-3BFCD4349D55Q35919777-44129EC8-1B43-4B5B-9FAB-D7C847B28A70Q36047584-554947FF-0834-46A7-8CAB-CE81F860FBE8Q36186533-5CA15E67-6ED1-4395-A3F8-4083C17A8E7CQ36238365-4CBFEB00-576B-4926-BDA9-0893E1E2D8E8Q36410759-2120C35C-EAFF-4B53-BA77-4032A7E2D2B2Q37042502-D16E195B-B9FF-4C57-9B99-A216C8DEF3E8Q37274444-9E72C068-B27A-4BF9-A697-F7FE3FC359BDQ37376821-D4F2FC5A-EB0A-4362-8C03-FA2EE939C323Q41772561-DD43E02B-BBC5-4C69-B646-75E6DA4D0E2F
P2860
Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evidence for shared recognitio ...... c, diabetogenic T cell clones.
@ast
Evidence for shared recognitio ...... c, diabetogenic T cell clones.
@en
type
label
Evidence for shared recognitio ...... c, diabetogenic T cell clones.
@ast
Evidence for shared recognitio ...... c, diabetogenic T cell clones.
@en
prefLabel
Evidence for shared recognitio ...... c, diabetogenic T cell clones.
@ast
Evidence for shared recognitio ...... c, diabetogenic T cell clones.
@en
P2093
P356
P1476
Evidence for shared recognitio ...... c, diabetogenic T cell clones.
@en
P2093
Cathleen Dobbs
Christian Münz
Hitoshi Kikutani
Kathryn Haskins
Ken Yamamoto
Kenji Yoshida
Naoko Nakano
Nobuhiro Kamikawaji
Takehiko Sasazuki
Tracy Martin
P304
P356
10.1093/INTIMM/DXF106
P577
2002-12-01T00:00:00Z